Psychosocial outcome and health-related quality of life (HRQoL) in advanced melanoma survivors.

Anne Rogiers; Jennifer De Cremer; Laila Ben Salama; Mark De Ridder; Jan Ouis Bernheim; Bart Neyns; Peter Theuns

Psychosocial outcome and health-related quality of life (HRQoL) in advanced melanoma survivors.

Anne Rogiers, Jennifer De Cremer, Laila Ben Salama, Mark De Ridder, Jan Ouis Bernheim, Bart Neyns, Peter Theuns

Research output: Contribution to journal › Meeting abstract (Journal)

Original language	English
Article number	162
Journal	Journal of Clinical Oncology
Volume	36
Issue number	7
Publication status	Published - 1 Mar 2018
Event	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 1 Jun 2018 → 5 Jun 2018

Keywords

HRQoL
melanoma
survivors

Handle.net

Persistent link

Cite this

@article{658be90864a44166a48b0aa516c90766,

title = "Psychosocial outcome and health-related quality of life (HRQoL) in advanced melanoma survivors.",

keywords = "HRQoL, melanoma, survivors",

author = "Anne Rogiers and {De Cremer}, Jennifer and {Ben Salama}, Laila and {De Ridder}, Mark and Bernheim, {Jan Ouis} and Bart Neyns and Peter Theuns",

year = "2018",

month = mar,

day = "1",

language = "English",

volume = "36",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "7",

note = "Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 01-06-2018 Through 05-06-2018",

}

TY - JOUR

T1 - Psychosocial outcome and health-related quality of life (HRQoL) in advanced melanoma survivors.

AU - Rogiers, Anne

AU - De Cremer, Jennifer

AU - Ben Salama, Laila

AU - De Ridder, Mark

AU - Bernheim, Jan Ouis

AU - Neyns, Bart

AU - Theuns, Peter

PY - 2018/3/1

Y1 - 2018/3/1

KW - HRQoL

KW - melanoma

KW - survivors

M3 - Meeting abstract (Journal)

SN - 0732-183X

VL - 36

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 7

M1 - 162

T2 - Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Y2 - 1 June 2018 through 5 June 2018

ER -